Press Release


Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
Jan 16, 2023 06:00 JST
PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (Nasdaq: SNGX) is on track to deliver a safe and effective front-line treatment to a community of patients living with rare, chronic cancer.
More info..

Latest Release


More Latest Release >>